gemcabene
Small moleculeexperimental
Clinical trial activity
12 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
9
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 1999 (NCT02587364)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O- Mol. weight
- 302.41 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2110686 ↗
Also known as
- 6,6'-oxybis(2,2-dimethylhexanoic acid)
- gemcabene
- gemcabene
- gemcabene
- gemcabene
- pd72953
- pd 72953
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03436420 | Phase 2 | Mar 29, 2018 | Emory University, Gemphire Therapeutics, Inc. |
| NCT03508687 | Phase 1/Phase 2 (Phase 2) | Mar 13, 2018 | University of Michigan |
| NCT02944383 | Phase 2 | Dec 1, 2016 | Gemphire Therapeutics, Inc. |
| NCT02634151 | Phase 2 | Nov 1, 2016 | Gemphire Therapeutics, Inc. |
| NCT02722408 | Phase 2 | May 1, 2016 | Gemphire Therapeutics, Inc. |
| NCT02591836 | Phase 2 | Jan 1, 2003 | Gemphire Therapeutics, Inc. |
| NCT02587416 | Phase 1 | Nov 1, 2002 | Gemphire Therapeutics, Inc. |
| NCT02586168 | Phase 2 | Jul 1, 2001 | Gemphire Therapeutics, Inc. |
| NCT02571257 | Phase 2 | Aug 1, 2000 | Gemphire Therapeutics, Inc. |
| NCT02587390 | Phase 1 | May 1, 2000 | Gemphire Therapeutics, Inc. |
| NCT02585869 | Phase 2 | Dec 1, 1999 | Gemphire Therapeutics, Inc. |
| NCT02587364 | Phase 1 | Apr 1, 1999 | Gemphire Therapeutics, Inc. |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gemphire Therapeutics, Inc. | For profit | 11 | 10 | 2 | 1999 |
| Emory University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1